Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism
Author:
Affiliation:
1. UAB Research Center of Excellence in Arsenicals, Department of Dermatology University of Alabama at Birmingham Birmingham Alabama USA
2. Department of Biology University of Alabama at Birmingham Birmingham Alabama USA
Funder
National Institutes of Health
National Institute of Environmental Health Sciences
Publisher
Wiley
Subject
Cancer Research,Molecular Biology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23414
Reference45 articles.
1. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005
2. The current landscape of rhabdomyosarcomas: an update
3. Rhabdomyosarcoma
4. Epidemiology, Incidence, and Survival of Rhabdomyosarcoma Subtypes: SEER and ICES Database Analysis
5. Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders;ACS Pharmacology & Translational Science;2024-02-06
2. BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma;EMBO Reports;2024-01-08
3. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease;Signal Transduction and Targeted Therapy;2023-10-02
4. Necroptosis in the sarcoma immune microenvironment: From biology to therapy;International Immunopharmacology;2023-09
5. BRD4 isoforms have distinct roles in tumor progression and metastasis in embryonal rhabdomyosarcoma;2023-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3